Exploring the potential public health benefits of universal influenza vaccine
Background: Broadly protective, long-lasting universal influenza vaccines are under development in response to low-moderate seasonal vaccine effectiveness, frequent genetic changes in circulating viruses and extended turnaround for vaccine manufacture. Because a long-lasting vaccine might be less ef...
Saved in:
Main Authors: | Jay V. DePasse (Author), Mary Patricia Nowalk (Author), Kenneth J. Smith (Author), Jonathan M. Raviotta (Author), Eunha Shim (Author), Richard K. Zimmerman (Author), Shawn T. Brown (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018-2019 and 2019-2020 calculated using a retrospective test-negative design
by: Richard K. Zimmerman, et al.
Published: (2023) -
Cost-effectiveness of the adjuvanted quadrivalent influenza vaccine for older adults in South Korea
by: Youngji Song, et al.
Published: (2024) -
Smoking and serological response to influenza vaccine
by: Won Suk Choi, et al.
Published: (2024) -
Cost effectiveness of a practice-based intervention to improve vaccination rates in adults less than 65-years-old
by: Kenneth J. Smith, et al.
Published: (2017) -
Does influenza vaccination status change physician ordering patterns for respiratory viral panels? Inspection for selection bias
by: G.K. Balasubramani, et al.
Published: (2019)